These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10758406)

  • 1. CD14, new aspects of ligand and signal diversity.
    Landmann R; Müller B; Zimmerli W
    Microbes Infect; 2000 Mar; 2(3):295-304. PubMed ID: 10758406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD14 in cellular recognition of bacterial lipopolysaccharides.
    Kitchens RL
    Chem Immunol; 2000; 74():61-82. PubMed ID: 10608082
    [No Abstract]   [Full Text] [Related]  

  • 3. Toll receptors, CD14, and macrophage activation and deactivation by LPS.
    Dobrovolskaia MA; Vogel SN
    Microbes Infect; 2002 Jul; 4(9):903-14. PubMed ID: 12106783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.
    Kirschning CJ; Wesche H; Merrill Ayres T; Rothe M
    J Exp Med; 1998 Dec; 188(11):2091-7. PubMed ID: 9841923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
    Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
    J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
    Means TK; Lien E; Yoshimura A; Wang S; Golenbock DT; Fenton MJ
    J Immunol; 1999 Dec; 163(12):6748-55. PubMed ID: 10586073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses.
    Schröder NW; Heine H; Alexander C; Manukyan M; Eckert J; Hamann L; Göbel UB; Schumann RR
    J Immunol; 2004 Aug; 173(4):2683-91. PubMed ID: 15294986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.
    Fujihara M; Muroi M; Tanamoto K; Suzuki T; Azuma H; Ikeda H
    Pharmacol Ther; 2003 Nov; 100(2):171-94. PubMed ID: 14609719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction.
    Hajishengallis G; Martin M; Sojar HT; Sharma A; Schifferle RE; DeNardin E; Russell MW; Genco RJ
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):403-11. PubMed ID: 11874886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic targets revealed through investigations of innate immunity.
    Ulevitch RJ
    Crit Care Med; 2001 Jul; 29(7 Suppl):S8-12. PubMed ID: 11445726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD14-mediated cellular responses to lipopolysaccharide.
    Tapping RI; Tobias PS
    Chem Immunol; 2000; 74():108-21. PubMed ID: 10608084
    [No Abstract]   [Full Text] [Related]  

  • 12. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation.
    Triantafilou M; Miyake K; Golenbock DT; Triantafilou K
    J Cell Sci; 2002 Jun; 115(Pt 12):2603-11. PubMed ID: 12045230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
    Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
    J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    Yoshimura A; Lien E; Ingalls RR; Tuomanen E; Dziarski R; Golenbock D
    J Immunol; 1999 Jul; 163(1):1-5. PubMed ID: 10384090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.
    Henneke P; Takeuchi O; van Strijp JA; Guttormsen HK; Smith JA; Schromm AB; Espevik TA; Akira S; Nizet V; Kasper DL; Golenbock DT
    J Immunol; 2001 Dec; 167(12):7069-76. PubMed ID: 11739528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors.
    Ingalls RR; Heine H; Lien E; Yoshimura A; Golenbock D
    Infect Dis Clin North Am; 1999 Jun; 13(2):341-53, vii. PubMed ID: 10340170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.
    Cario E; Rosenberg IM; Brandwein SL; Beck PL; Reinecker HC; Podolsky DK
    J Immunol; 2000 Jan; 164(2):966-72. PubMed ID: 10623846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B.
    Jiang Q; Akashi S; Miyake K; Petty HR
    J Immunol; 2000 Oct; 165(7):3541-4. PubMed ID: 11034352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster.
    Triantafilou M; Triantafilou K
    Trends Immunol; 2002 Jun; 23(6):301-4. PubMed ID: 12072369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide.
    Flo TH; Halaas O; Lien E; Ryan L; Teti G; Golenbock DT; Sundan A; Espevik T
    J Immunol; 2000 Feb; 164(4):2064-9. PubMed ID: 10657659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.